AEterna Zentaris Company
.jpg)
AEterna Zentaris is a drug development company that specializes in oncology and endocrine therapy.
Total Funding:
$72 910 000
Headquarters:
Quebec, Quebec, Canada
Funding Status:
IPO
Last Funding Type:
Post-IPO Equity
Last Funding Date:
2021-02-16
Founded Date:
1991-01-01
Industry:
Women Cancer Treatment